Your cart:£ 0.00(0 items) Check yourbonu$
Site search:
Categories list

Generic Etoposide - Vepesid

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Vepesid

Generic Vepesid

Etoposide 50mg

Generic Vepesid is used for treating patients with lung cancer and recurrent testicular tumors. It is used in combination with other cancer medications. VePesid is an antineoplastic. It works by stopping the tumor cells from dividing (mitosis), which prevents the spread of certain types of cancer.

More info »
£ 6.29 Buy now!
Country, language and currency
Social bookmarks:
Testimonials
I received both packets a few weeks ago and I am very pleased with the service. Thank you for the extra 4 samples. When dealing with people so far away, and through the internet, I sometimes wonder if I will even receive anything for my money. I would not hesitate to use your services again or to recommend you to friends. Again, Thank You.
Read more »
Special Offer!

Brave boy, 2, successfully battles brain tumour - and doctors hope pioneering ... - Daily Mail
Daily MailBrave boy, 2, successfully battles brain tumour - and doctors hope pioneering
Diffuse Large B-Cell Lymphoma: Current Treatment Approaches - Cancer Network
Diffuse Large B-Cell Lymphoma: Current Treatment ApproachesCancer Network[32] Patients with an unfavorable interim PET/CT after two cycles of R-CHOP received R-DICEP (rituximab, dose-intensive cyclophosphamide, etoposide, cisplatin) followed by R-BEAM (rituximab, carmustine [BCNU], etoposide, Ara-C [cytarabine],
Large-scale study finds treatment standard for rare cancer - HealthCanal.com
Large-scale study finds treatment standard for rare cancerHealthCanal
Mitotane plus Chemo Combo May Benefit Adrenocortical Cancer - MD News (press release)
Mitotane plus Chemo Combo May Benefit Adrenocortical CancerMD News (press release)For patients with advanced adrenocortical cancer, mitotane plus a combination of etoposide, doxorubicin, and cisplatin is superior to streptozocin-mitotane for rates of response and progression-free survival, but does not improve overall survival
The Challenge of Answering Multiple Questions in a Single Oncology Trial - Clinical Oncology News
Clinical Oncology NewsThe Challenge of Answering Multiple Questions in a Single Oncology TrialClinical Oncology NewsFortunately, subsequent research revealed that including etoposide, rather than doubling the cisplatin concentration, was the cause of the superior clinical outcomes with this primary chemotherapy program
bookmark Bookmark this site
Subscribe to the News